New

Female Sexual Dysfunction Treatment Market

2021

Female Sexual Dysfunction Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Non-Hormonal Therapy, Hormonal Therapy), and Geography

| Report Code: TIPRE00015564 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Female Sexual Dysfunction Treatment Market 2028 By Type, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Sexual dysfunction refers to a psychiatric disorder that leads to a continuous or repeated failure to cause sexual excitement. Treatment is typically performed by treating primary care providers for this dysfunction, while ED physicians may be consulted. Women have been found to be more vulnerable to sexual dysfunction than men. Female sexual dysfunction may occur or may persist or occur a few times at any point in life. Physical or psychiatric problems with sexual dysfunction may occur.

MARKET DYNAMICS

Increasing prevalence of chronic diseases in women would lead to an increased incidence of sexual problems for women. This will provide important market opportunities for future growth. Moreover, the industry is expected to see healthy growth due to technological advances, increasing health concerns and higher expenditure in the health sector.

MARKET SCOPE

The "Female Sexual Dysfunction Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Female Sexual Dysfunction Treatment Market with detailed market segmentation by product type, and application. The Female Sexual Dysfunction Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Female Sexual Dysfunction Treatment Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Female Sexual Dysfunction Treatment Market is segmented on the basis of type, the market is segmented as Non-Hormonal Therapy, Hormonal Therapy.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Female Sexual Dysfunction Treatment Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Female Sexual Dysfunction Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Female Sexual Dysfunction Treatment Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Female Sexual Dysfunction Treatment Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Female Sexual Dysfunction Treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Female Sexual Dysfunction Treatment Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Female Sexual Dysfunction Treatment Market in the global market. Below mentioned is the list of few companies engaged in the Female Sexual Dysfunction Treatment Market.

The report also includes the profiles of key players in Female Sexual Dysfunction Treatment Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Apricus Biosciences, Inc.
  •   GlaxoSmithKline, plc.
  •   Pfizer, Inc.
  •   Merck and Co.
  •   Cipla
  •   AMAG Pharmaceuticals Inc.
  •   Novo Nordisk AS
  •   Sprout Pharmaceuticals Inc.
  •   Duchesnay Inc.
  •   Emotional Brain BV

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Female Sexual Dysfunction Treatment Market - By Type
1.3.2 Female Sexual Dysfunction Treatment Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. FEMALE SEXUAL DYSFUNCTION TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. FEMALE SEXUAL DYSFUNCTION TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. FEMALE SEXUAL DYSFUNCTION TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. FEMALE SEXUAL DYSFUNCTION TREATMENT - GLOBAL MARKET OVERVIEW
6.2. FEMALE SEXUAL DYSFUNCTION TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. FEMALE SEXUAL DYSFUNCTION TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. NON-HORMONAL THERAPY
7.3.1. Overview
7.3.2. Non-Hormonal Therapy Market Forecast and Analysis
7.4. HORMONAL THERAPY
7.4.1. Overview
7.4.2. Hormonal Therapy Market Forecast and Analysis
8. FEMALE SEXUAL DYSFUNCTION TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Female Sexual Dysfunction Treatment Market Overview
8.1.2 North America Female Sexual Dysfunction Treatment Market Forecasts and Analysis
8.1.3 North America Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Type
8.1.4 North America Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Countries
8.1.4.1 United States Female Sexual Dysfunction Treatment Market
8.1.4.1.1 United States Female Sexual Dysfunction Treatment Market by Type
8.1.4.2 Canada Female Sexual Dysfunction Treatment Market
8.1.4.2.1 Canada Female Sexual Dysfunction Treatment Market by Type
8.1.4.3 Mexico Female Sexual Dysfunction Treatment Market
8.1.4.3.1 Mexico Female Sexual Dysfunction Treatment Market by Type
8.2. EUROPE
8.2.1 Europe Female Sexual Dysfunction Treatment Market Overview
8.2.2 Europe Female Sexual Dysfunction Treatment Market Forecasts and Analysis
8.2.3 Europe Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Type
8.2.4 Europe Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Female Sexual Dysfunction Treatment Market
8.2.4.1.1 Germany Female Sexual Dysfunction Treatment Market by Type
8.2.4.2 France Female Sexual Dysfunction Treatment Market
8.2.4.2.1 France Female Sexual Dysfunction Treatment Market by Type
8.2.4.3 Italy Female Sexual Dysfunction Treatment Market
8.2.4.3.1 Italy Female Sexual Dysfunction Treatment Market by Type
8.2.4.4 Spain Female Sexual Dysfunction Treatment Market
8.2.4.4.1 Spain Female Sexual Dysfunction Treatment Market by Type
8.2.4.5 United Kingdom Female Sexual Dysfunction Treatment Market
8.2.4.5.1 United Kingdom Female Sexual Dysfunction Treatment Market by Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Female Sexual Dysfunction Treatment Market Overview
8.3.2 Asia-Pacific Female Sexual Dysfunction Treatment Market Forecasts and Analysis
8.3.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Type
8.3.4 Asia-Pacific Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Female Sexual Dysfunction Treatment Market
8.3.4.1.1 Australia Female Sexual Dysfunction Treatment Market by Type
8.3.4.2 China Female Sexual Dysfunction Treatment Market
8.3.4.2.1 China Female Sexual Dysfunction Treatment Market by Type
8.3.4.3 India Female Sexual Dysfunction Treatment Market
8.3.4.3.1 India Female Sexual Dysfunction Treatment Market by Type
8.3.4.4 Japan Female Sexual Dysfunction Treatment Market
8.3.4.4.1 Japan Female Sexual Dysfunction Treatment Market by Type
8.3.4.5 South Korea Female Sexual Dysfunction Treatment Market
8.3.4.5.1 South Korea Female Sexual Dysfunction Treatment Market by Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Female Sexual Dysfunction Treatment Market Overview
8.4.2 Middle East and Africa Female Sexual Dysfunction Treatment Market Forecasts and Analysis
8.4.3 Middle East and Africa Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Type
8.4.4 Middle East and Africa Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Female Sexual Dysfunction Treatment Market
8.4.4.1.1 South Africa Female Sexual Dysfunction Treatment Market by Type
8.4.4.2 Saudi Arabia Female Sexual Dysfunction Treatment Market
8.4.4.2.1 Saudi Arabia Female Sexual Dysfunction Treatment Market by Type
8.4.4.3 U.A.E Female Sexual Dysfunction Treatment Market
8.4.4.3.1 U.A.E Female Sexual Dysfunction Treatment Market by Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Female Sexual Dysfunction Treatment Market Overview
8.5.2 South and Central America Female Sexual Dysfunction Treatment Market Forecasts and Analysis
8.5.3 South and Central America Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Type
8.5.4 South and Central America Female Sexual Dysfunction Treatment Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Female Sexual Dysfunction Treatment Market
8.5.4.1.1 Brazil Female Sexual Dysfunction Treatment Market by Type
8.5.4.2 Argentina Female Sexual Dysfunction Treatment Market
8.5.4.2.1 Argentina Female Sexual Dysfunction Treatment Market by Type
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL FEMALE SEXUAL DYSFUNCTION TREATMENT MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. FEMALE SEXUAL DYSFUNCTION TREATMENT MARKET, KEY COMPANY PROFILES
11.1. APRICUS BIOSCIENCES, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLAXOSMITHKLINE, PLC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MERCK AND CO.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CIPLA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. AMAG PHARMACEUTICALS INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVO NORDISK AS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SPROUT PHARMACEUTICALS INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. DUCHESNAY INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. EMOTIONAL BRAIN BV
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Apricus Biosciences, Inc.
2. GlaxoSmithKline, plc.
3. Pfizer, Inc.
4. Merck and Co.
5. Cipla
6. AMAG Pharmaceuticals Inc.
7. Novo Nordisk AS
8. Sprout Pharmaceuticals Inc.
9. Duchesnay Inc.
10. Emotional Brain BV
TIPRE00015564
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.